Amrutanjan Health Care Limited (BOM:590006)
India · Delayed Price · Currency is INR 625.60
+12.95 (2.11%)
At close: Jan 22, 2026
Amrutanjan Health Care Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 566.96 | 508.35 | 449.73 | 398.35 | 671.89 | 611.9 | Upgrade |
Depreciation & Amortization | 54.19 | 55.7 | 52.08 | 44.18 | 36.56 | 35.04 | Upgrade |
Other Amortization | 9.56 | 9.56 | 8.49 | 7.94 | 1.39 | 1.66 | Upgrade |
Loss (Gain) From Sale of Assets | -1.04 | - | -1.57 | -0.27 | - | -0.89 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | 1.11 | - | - | - | Upgrade |
Loss (Gain) From Sale of Investments | 0.12 | -0.02 | 1.26 | 2.05 | 1.41 | 3.67 | Upgrade |
Stock-Based Compensation | 15.22 | 11.45 | 2.15 | 4.38 | -0.11 | 6.18 | Upgrade |
Provision & Write-off of Bad Debts | -4.01 | 2.64 | 20.99 | 4.64 | 3.99 | 15.98 | Upgrade |
Other Operating Activities | -151.22 | -168.88 | -153.25 | -163.04 | -153.89 | -70.96 | Upgrade |
Change in Accounts Receivable | -32.69 | -81.96 | -169.68 | 47.72 | -209.92 | 72.55 | Upgrade |
Change in Inventory | -28.68 | 16.45 | -0.8 | -28.24 | -85.42 | 62.57 | Upgrade |
Change in Accounts Payable | 57.15 | 146.17 | 95.41 | -106.67 | 236.79 | 94.99 | Upgrade |
Change in Other Net Operating Assets | -29.71 | 9.54 | -26.81 | -9.22 | 19.27 | 76.01 | Upgrade |
Operating Cash Flow | 455.84 | 508.99 | 279.11 | 201.81 | 521.96 | 908.69 | Upgrade |
Operating Cash Flow Growth | 82.73% | 82.36% | 38.30% | -61.34% | -42.56% | 399.94% | Upgrade |
Capital Expenditures | -506.84 | -355.53 | -67.18 | -89.27 | -234.63 | -19.61 | Upgrade |
Sale of Property, Plant & Equipment | 1.04 | - | 2.59 | 0.44 | - | 0.89 | Upgrade |
Investment in Securities | 6.22 | -114.61 | 115.04 | -48.25 | -253.82 | -915.27 | Upgrade |
Other Investing Activities | 161.35 | 160.48 | 141.2 | 112.33 | 126.34 | 56.38 | Upgrade |
Investing Cash Flow | -338.23 | -309.66 | 191.65 | -24.75 | -362.12 | -877.61 | Upgrade |
Long-Term Debt Repaid | - | -4.61 | -5.57 | -5.8 | -6.92 | -6.42 | Upgrade |
Total Debt Repaid | -4.91 | -4.61 | -5.57 | -5.8 | -6.92 | -6.42 | Upgrade |
Net Debt Issued (Repaid) | -4.91 | -4.61 | -5.57 | -5.8 | -6.92 | -6.42 | Upgrade |
Issuance of Common Stock | 0.75 | 2.38 | 11.79 | - | - | - | Upgrade |
Repurchase of Common Stock | - | - | -355.02 | - | -35.34 | -9.64 | Upgrade |
Common Dividends Paid | -132.67 | -132.67 | -133.86 | -144.09 | -124.77 | -57.83 | Upgrade |
Other Financing Activities | - | - | - | - | - | -0.33 | Upgrade |
Financing Cash Flow | -136.82 | -134.9 | -482.66 | -149.89 | -167.02 | -74.23 | Upgrade |
Foreign Exchange Rate Adjustments | - | - | - | - | -0 | -0.01 | Upgrade |
Net Cash Flow | -19.21 | 64.43 | -11.91 | 27.17 | -7.19 | -43.16 | Upgrade |
Free Cash Flow | -51 | 153.46 | 211.93 | 112.54 | 287.32 | 889.09 | Upgrade |
Free Cash Flow Growth | - | -27.59% | 88.31% | -60.83% | -67.68% | 468.77% | Upgrade |
Free Cash Flow Margin | -1.08% | 3.40% | 5.03% | 2.96% | 7.08% | 26.70% | Upgrade |
Free Cash Flow Per Share | -1.76 | 5.31 | 7.30 | 3.85 | 9.83 | 30.41 | Upgrade |
Cash Interest Paid | - | - | - | - | - | 0.33 | Upgrade |
Cash Income Tax Paid | 185.09 | 179.23 | 164.97 | 160.63 | 241.92 | 186.97 | Upgrade |
Levered Free Cash Flow | -91.28 | 129.83 | 250.33 | 45.23 | 293.5 | 816.5 | Upgrade |
Unlevered Free Cash Flow | -90.02 | 131.2 | 251.31 | 45.71 | 296.53 | 819.63 | Upgrade |
Change in Working Capital | -33.94 | 90.2 | -101.88 | -96.4 | -39.29 | 306.12 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.